#
- 177Lu-DOTA-Tyr-octreotate2
- 1型神经纤维瘤病(NF1)3
- 1型酪氨酸血症4
- 2型神经元蜡样脂褐质沉积症(CLN2)1
- 4SC AG1
- α-甘露糖苷贮积症1
- β地中海贫血7
- 丁型肝炎病毒感染1
- 亨廷顿病1
- 伴KRAS G12C突变的结直肠癌1
- 伴KRAS G12C突变的非小细胞肺癌1
- 伴NTRK基因融合的实体瘤3
- 伴嗜酸性粒细胞增多的髓系和淋巴系肿瘤1
- 伴多血管炎的肉芽肿病(Wegener肉芽肿病)3
- 伴肺气肿的α-1抗胰蛋白酶缺乏症3
- 低磷酸盐性佝偻病1
- 低磷酸酶症2
- 侵袭性念珠菌病1
- 侵袭性曲霉病2
- 假弹性黄瘤1
- 储袋炎1
- 先天性凝血因子VII缺乏症1
- 先天性原发性胆汁酸合成缺陷1
- 先天性肾上腺皮质增生症(CAH)1
- 免疫性血小板减少症(ITP)7
- 全身型幼年特发性关节炎(sJIA)2
- 全身性脓疱型银屑病(GPP)2
- 再生障碍性贫血1
- 冷吡啉相关周期性综合征(CAPS)2
- 利什曼病3
- 动脉瘤性蛛网膜下腔出血1
- 包涵体肌炎1
- 卵巢癌11
- 原发性IgA肾病7
- 原发性恶性骨肿瘤1
- 原发性硬化性胆管炎(PSC)1
- 原发性胆汁性胆管炎(PBC)3
- 原发性腹膜癌1
- 原发性膜增生性肾小球肾炎1
- 原发性膜性肾病1
- 原发性血小板增多症2
- 原发性高草酸尿症1
- 发作性睡病2
- 嗜酸性食管炎2
- 器官移植中的缺血-再灌注损伤1
- 噬血细胞性淋巴组织细胞增生症(HLH)1
- 囊性纤维化11
- 囊性纤维化患者的细菌性肺部感染2
- 增殖性婴儿血管瘤1
- 外周T细胞淋巴瘤(PTCL)3
- 多发性骨髓瘤28
- 大疱性表皮松解症2
- 套细胞淋巴瘤11
- 实体器官移植后的移植排斥反应5
- 家族性乳糜微粒血症综合征(FCS)2
- 家族性地中海热(FMF)1
- 家族性淀粉样多发性神经病1
- 家族性腺瘤性息肉病(FAP)2
- 小细胞肺癌(SCLC)17
- 尿素循环障碍(高氨血症)5
- 局灶节段性肾小球硬化(FSGS)1
- 巨细胞病毒感染(CMV)5
- 常染色体显性多囊肾病(ADPKD)1
- 干细胞移植前预处理10
- 幼年类风湿性关节炎1
- 库欣综合征3
- 异染性脑白质营养不良(MLD)1
- 弗里德赖希共济失调3
- 弥漫性大B细胞淋巴瘤(DLBCL)17
- 急性早幼粒细胞白血病(APL)2
- 急性淋巴细胞白血病(ALL)14
- 急性肝卟啉病1
- 急性髓系白血病(AML)15
- 恶性腹水1
- 恶性间皮瘤4
- 恶性高热1
- 恶性黑色素瘤1
- 慢性嗜酸性粒细胞白血病和高嗜酸性粒细胞综合征3
- 慢性淋巴细胞白血病(CLL)10
- 慢性炎性脱髓鞘性多发性神经根神经病(CIDP)2
- 慢性疼痛的鞘内镇痛1
- 慢性肉芽肿病1
- 慢性血栓栓塞性肺动脉高压(CTEPH)6
- 慢性非感染性葡萄膜炎1
- 慢性髓性白血病(CML)7
- 成人发病型Still病1
- 日本脑炎1
- 早产儿原发性呼吸暂停1
- 春季角结膜炎1
- 晚期特发性帕金森病1
- 暴露后狂犬病预防1
- 有症状的肥厚型心肌病2
- 杜氏肌营养不良症6
- 母细胞样浆细胞样树突状细胞肿瘤(BPDCN)1
- 毛细胞白血病(HCL)1
- 毛霉菌病2
- 深Ⅱ度和全层烧伤3
- 混合型卟啉病1
- 滤泡性淋巴瘤15
- 片形吸虫病1
- 特发性肺纤维化(IPF)7
- 狼疮性肾炎(LN)1
- 生长激素缺乏症2
- 甲氨蝶呤毒性1
- 甲状旁腺功能减退症1
- 甲状腺癌4
- 甲状腺髓样癌(MTC)1
- 疟疾4
- 瘦素受体缺乏症(LEPR)1
- 皮肌炎(DM)1
- 皮肤T细胞淋巴瘤5
- 真性红细胞增多症3
- 着色性干皮病1
- 短肠综合征2
- 视神经脊髓炎谱系疾病(NMOSD)4
- 神经内分泌肿瘤(NET)10
- 神经母细胞瘤4
- 神经营养性角膜炎1
- 移植后淋巴增殖性疾病(PTLD)1
- 移植物抗宿主病(GvHD)3
- 类癌综合征1
- 系统性硬化症(硬皮病)7
- 红细胞生成性卟啉病1
- 纯合子家族性高胆固醇血症(HoFH)1
- 结核病(MDR/XDR)1
- 结节性硬化症(TSC)6
- 肌萎缩侧索硬化症(ALS)8
- 肛瘘1
- 肛门癌1
- 肝细胞癌(HCC)5
- 肝静脉闭塞性疾病(VOD)2
- 肢端肥大症2
- 肥大细胞增多症4
- 肺动脉高压(PAH)27
- 肾上腺功能不全1
- 肾上腺皮质癌1
- 肾上腺脑白质营养不良(ALD)1
- 肾病型胱氨酸病4
- 肾细胞癌7
- 胃癌6
- 胃肠道间质瘤(GIST)7
- 胆管癌(胆道癌)4
- 胰岛细胞癌1
- 胰腺癌7
- 胱氨酸尿症1
- 胶质瘤和胶质母细胞瘤8
- 脆性X综合征1
- 脊髓性肌萎缩症(SMA)6
- 脊髓损伤1
- 脑腱黄瘤病(CTX)1
- 腱鞘巨细胞瘤3
- 自身免疫性溶血性贫血1
- 苯丙酮尿症(高苯丙氨酸血症)5
- 获得性下丘脑性肥胖1
- 葡萄球菌性肠炎1
- 葡萄膜炎性黄斑水肿1
- 葡萄膜黑色素瘤1
- 蒽环类药物外渗1
- 血友病A14
- 血友病B8
- 血栓性血小板减少性紫癜(TTP)3
- 转甲状腺素蛋白淀粉样变性(ATTR)8
- 软组织肉瘤9
- 软骨发育不全2
- 软骨肉瘤1
- 输卵管癌1
- 输血性铁过载4
- 边缘区淋巴瘤(MZL)5
- 进行性家族性肝内胆汁淤积症(PFIC)2
- 进行性骨化性纤维发育不良(FOP)1
- 遗传性凝血因子XIII缺乏症1
- 遗传性凝血因子X缺乏症1
- 遗传性视网膜营养不良1
- 遗传性血管性水肿(HAE)12
- 重度先天性蛋白C缺乏症1
- 重度海洛因依赖3
- 重症肌无力9
- 铜绿假单胞菌引起的肺炎1
- 镰状细胞病5
- 间变性大细胞淋巴瘤(ALCL)1
- 阵发性睡眠性血红蛋白尿(PNH)6
- 阿黑皮质素原缺乏症(POMC)1
- 隆突性皮肤纤维肉瘤(DFSP)2
- 霍奇金淋巴瘤3
- 非典型溶血性尿毒综合征(aHUS)3
- 颈肌张力障碍1
- 食管癌1
- 骨肉瘤1
- 骨髓增生异常综合征(MDS)10
- 骨髓纤维化11
- 高免疫球蛋白D综合征(HIDS)1
- 高级别B细胞淋巴瘤1
- 黏多糖贮积症(MPS)5
A
- AA淀粉样变1
- AbbVie AG9
- Abecma
- acalabrutinibum3
- Accord Healthcare AG1
- Acido chenodesossicolico Leadiant
- acidum aceneuramicum1
- acidum carglumicum4
- acidum chenodeoxycholicum1
- acidum cholicum1
- acidum norucholicum1
- acidum obeticholicum1
- acoramidisum1
- Actelion Pharmaceuticals Ltd1
- adagrasibum1
- Adcetris
- Adcirca
- Adempas
- Adempas junior
- ADIENNE SA8
- admilparantum1
- ADVANCED ACCELERATOR APPLICATIONS (SWITZERLAND) SA1
- Advanz Pharma Specialty Medicine Switzerland GmbH1
- Adzynma
- afamelanotidum4
- aficamtenum1
- Afstyla
- agalsidasum alfa1
- Agamree
- Ageronix SA1
- Agilus
- AL-S Pharma AG1
- Alagille综合征2
- alaninati brivanibum1
- albutrepenonacogum alfa1
- Alecensa
- alectinibum1
- Alexion Pharma GmbH21
- Alfasigma Schweiz AG2
- alglucosidasum alfa1
- Alhemo
- alicaforsenum1
- allogeneic cultured adult human mesenchymal stem cells1
- Alnylam Switzerland GmbH4
- alpelisibum1
- alpha-1-proteinasi inhibitor humanum4
- Alprolix
- Altuvoct
- Alunbrig
- ALXN22201
- Alyftrek
- AL淀粉样变(轻链淀粉样变)5
- Ambrisentan OrPha
- ambrisentanum2
- Amgen Switzerland AG8
- Amicus Therapeutics Switzerland GmbH3
- amifampridinum1
- AMVUTTRA®
- anagrelidum2
- Andembry
- Andembry
- anetumabum ravtansinum1
- anitocabtagenum autoleucelum1
- anselamimabum1
- apadamtasum alfa2
- apitegromabum1
- apraglutidum1
- argenx Switzerland SA3
- arlocabtagenum autoleucelum1
- Arog Pharmaceuticals Europe Ltd, c/o TMF Groupe1
- arsenii trioxidum1
- artemetherum, lumefantrinum1
- Ascendis Pharma Switzerland GmbH2
- asciminibum1
- Aspaveli
- Astellas Pharma AG2
- AstraZeneca AG10
- atalurenum1
- Atgam
- atidarsagenum autotemcelum1
- atigotatugum, nivolumabum1
- Atlantic Healthcare plc1
- atrasentanum1
- Atriance
- autologous adipose-derived stem cells1
- autologous cultured dendritic cells with Ag CD86, ...1
- autologous cultured keratinocytes1
- avacopanum3
- avalglucosidasum alfa1
- avapritinibum2
- avatrombopagi maleas1
- avelumabum1
- axicabtagenum ciloleucelum4
- axitinibum1
- Ayvakyt
- azacitidinum3
- aztreonamum1
B
- BACOBA AG1
- Bardet-Biedl综合征(BBS)1
- Basilea Pharmaceutica International AG, Allschwil4
- Bavencio
- Bayer (Schweiz) AG14
- bedaquilini fumaras1
- begelomabum1
- belantamabum mafodotinum1
- belumosudili mesilas1
- belzutifanum1
- BeOne Medicines I GmbH11
- beremagenum geperpavecum1
- Berirab
- berotralstati dihydrochloridum1
- Besponsa
- Besremi
- betulae corticis extractum1
- bevacizumabum5
- BEYONTTRA
- bimagrumabum1
- BioCryst Schweiz GmbH1
- Biogen Switzerland AG6
- Biotest (Schweiz) AG1
- Blenrep
- blinatumomabum1
- Blincyto
- Blueprint Medicines (Switzerland) GmbH4
- Boehringer Ingelheim (Schweiz) GmbH5
- bortezomibum2
- Bosentan-Mepha
- bosentanum9
- Bosulif
- bosutinibum1
- brentuximabum vedotinum4
- brexucaptagenum autoleucelum2
- Breyanzi
- brigatinibum1
- Bristol-Myers Squibb SA43
- bromelainum ex truncus1
- Brukinsa
- Brukinsa
- budesonidum2
- bulevirtidum1
- burosumabum1
- busulfanum1
- Bylvay
- B细胞非霍奇金淋巴瘤1
C
- C1-esterasi inhibitor humanus1
- C3肾小球病3
- Cablivi
- Calquence
- Camzyos
- canakinumabum9
- cannabidiolum3
- caplacizumabum1
- capmatinibum1
- Caprelsa
- Carbaglu
- carfilzomibum1
- carmustinum2
- Carvykti
- Casgevy
- Castleman病1
- catumaxomabum3
- Cayston
- CD PHARMA (SUISSE) SA1
- CDKL5缺乏症1
- cedazuridinum2
- Celgene International Sàrl3
- cendakimabum1
- cenegerminum1
- Centre hospitalier universitaire vaudois (CHUV)1
- Ceprotin
- Cerdelga
- cerliponasum alfa1
- Charcot-Marie-Tooth病1
- Cheplapharm Schweiz GmbH1
- Chiesi Farmaceutici SpA3
- Chiesi SA6
- chimeric monoclonal antibody to mesothelin1
- chininum1
- chlormethinum1
- ciclosporinum1
- cilengitidum1
- ciltacabtagenum autoleucelum1
- cipaglucosidasum alfa1
- ciprofloxacinum1
- clazosentanum1
- Clinigen Group plc Pitcairn House, c/o Proreo Pharma1
- Clinuvel AG4
- clofarabinum1
- coffeini citras1
- Columvi
- concizumabum2
- conestatum alfa1
- Cosan GmbH1
- CPS Cito Pharma Services GmbH1
- crenolanibi besilas1
- Cresemba
- Cresemba
- crisantaspasum1
- crizanlizumabum1
- crizotinibum1
- crovalimabum1
- Crysvita
- CSL Behring AG8
- CSL Behring Lengnau AG2
- Cuprior
- Curatis AG3
- Cyramza
- Cystadrops
- cytarabinum, daunorubicinum1
D
- Dacogen
- dacomitinibum1
- Daiichi Sankyo (Schweiz) AG4
- damoctocogum alfa pegolum1
- danicopanum1
- dantrolenum natricum hemiheptahydricum1
- daratumumabum4
- daraxonrasibum1
- darvadstrocelum1
- Darzalex
- DARZALEX SC
- dasatinibum2
- Dawnzera
- Deciphera Pharmaceuticals (Schweiz) AG2
- decitabinum1
- Deferasirox NOBEL
- deferasiroxum8
- defibrotidum2
- Defitelio
- delandistrogenum moxeparvovecum1
- denecimigum1
- Desitin Pharma GmbH1
- deucrictibantum1
- dexpramipexolum1
- dexrazoxanum1
- Diacomit
- Diacomit
- diamorphinum3
- Diaphin i.v.
- Diaphin IR 200
- Diaphin SR 200
- dinutuximabum beta1
- Dompé International SA1
- donidalorsenum1
- Doptelet
- doxorubicinum1
- Dr. Falk Pharma AG2
- DRAC AG6
- Dravet综合征4
- Dudler Pharma Sàrl1
- Duodopa
E
- Ebvallo
- ecallantidum1
- eculizumabum5
- edaravonum2
- efanesoctocogum alfa1
- EFFIK SA1
- EffRx Pharmaceuticals SA2
- efgartigimodum alfa3
- eflornithini hydrochloridum monohydricum1
- eflornithinum2
- Efmody
- efmoroctocogum alfa1
- eftrenonacogum alfa1
- efzimfotasum alfa1
- Eisai Pharma AG8
- Ekterly
- elafibranorum1
- ELAHERE
- Elaprase
- elexacaftorum2
- Elfabrio
- Eli Lilly (Suisse) SA9
- eliglustatum1
- Elocta
- elotuzumabum1
- elranatamabum1
- Elrexfio
- eltrombopagum1
- Elzonris 1mg / ml
- emapalumabum1
- emicizumabum1
- Empliciti
- enasidenibum1
- ENB-00401
- Enjaymo
- Enrylaze
- Enspryng
- entrectinibum2
- enzephalitidis japanensis viri antigenum1
- epcoritamabum4
- Epidyolex
- eplontersenum1
- epoprostenolum1
- eprodisatum1
- erlotinibum2
- Esbriet
- Esperoct
- etentamigum1
- etranacogenum dezaparvovecum1
- everolimusum6
- evinacumabum1
- Evrysdi
- Evrysdi
- exagamglogenum autotemcelum2
- Exjade
- Ezmekly
- Ezmekly
F
- Fabhalta
- Fabry病3
- factor X coagulationis humanus1
- Faktor X P Behring
- farletuzumabum1
- Farydak
- fedratinibum1
- felzartamabum3
- fenfluramini hydrochloridum3
- fidanacogenum elaparvovecum1
- Filspari
- Filsuvez
- fingolimodum1
- Fintepla
- Firazyr
- Firdapse
- Folotyn
- fordadistrogenum movaparvovecum1
- Fresenius Kabi (Schweiz) AG3
- futibatinibum1
- Future Health Pharma GmbH5
G
- Galafold
- gallii(68-Ga) dotatas1
- gallii(68-Ga) edotreotas1
- galsulfasum1
- ganaplacidum, lumefantrinum1
- gangliosidum GM11
- garadacimabum2
- Gaucher病3
- Gazyvaro
- Gebro Pharma AG1
- gefurulimabum1
- gemtuzumabum ozogamicinum1
- Gilead Sciences Switzerland Sàrl11
- gilteritinibum1
- giroctocogenum fitelparvovecum1
- givinostatum1
- Givlaari
- givosiranum natricum1
- glasdegibum1
- Glassia
- GlaxoSmithKline AG8
- Glivec
- Glivec GIST
- glofitamabum1
- glucarpidasum1
- glutaminum1
- GNE肌病1
- golcadomidi hydrochloridum2
- Gorlin综合征(痣样基底细胞癌综合征)1
- GRAFALON
- guadecitabinum1
H
I
- ianalumabum1
- iberdomidum1
- ibrutinibum4
- icatibantum1
- Iclusig
- idebenonum5
- idecabtagenum vicleucelum1
- Idefirix
- Idelvion
- IDEOGEN AG8
- Idorsia Pharmaceuticals Ltd1
- idursulfasum1
- ifinatamabum deruxtecanum1
- Ifinwil
- Ilaris
- Imaavy
- Imatinib GIST-Teva
- Imatinib-Teva
- imatinibi mesilas6
- imatinibum10
- Imbruvica
- IMCIVREE
- Imdylltra
- Imjudo
- imlifidasum1
- Immunocore GmbH1
- immunoglobulinum anti-T limphocytorum ex cuniculus2
- immunoglobulinum anti-T limphocytorum ex equus1
- immunoglobulinum humanum anti-rabies1
- immunoglobulinum humanum normale, immunoglobulinum humanum cytomegalicum1
- Imnovid
- Incyte Biosciences International Sàrl8
- inebilizumabum1
- Inlyta
- InnoMedica Schweiz AG2
- inotersenum natricum1
- inotuzumabum ozogamicinum1
- Inovelon
- Inovelon
- IPSEN Pharma Schweiz GmbH6
- iptacopanum3
- IQONE HEALTHCARE SWITZERLAND SA2
- irinotecani hydrochloridum trihydricum1
- isatuximabum1
- isavuconazonium4
- Isturisa
- ivacaftorum2
- ivacaftorum, lumacaftorum2
- ivosidenibum4
- ixazomibum2
- IXIARO
J
K
L
- Laboratoires CTRS1
- Lambert-Eaton肌无力综合征(LEMS)1
- Lamzede
- lanadelumabum2
- laronidasum1
- larotrectinibum2
- LCQ908 - DGAT-1-inhibitor1
- Leber遗传性视神经病变(LHON)2
- lebrikizumabum1
- Ledaga
- lefleugananum1
- Leman SKL SA1
- lenalidomidum7
- Lennox-Gastaut综合征4
- lenvatinibum2
- Lenvima
- Leo Pharmaceutical Products Sarath Ltd.2
- leriglitazoni hydrochloridum1
- letermovirum3
- levodopum, carbidopum1
- linvoseltamabum1
- Lipomed AG1
- lisocabtagenum maraleucelum6
- Livmarli
- Livtencity
- loncastuximabum tesirinum1
- lonoctocogum alfa1
- lumasiranum1
- Lunsumio
- Lunsumio subkutan
- Lupkynis
- lurbinectedinum4
- luspaterceptum4
- Lutathera 370 MBq/ml
- Lutathera CA
- Luxturna
- LXE4081
- Lysodren
- Lytgobi
- Lyvdelzi
M
- Mab minibody against C52
- Macitentan Leman
- Macitentan NOBEL
- macitentanum5
- macitentanum, tadalafilum1
- magrolimabum1
- mannitolum1
- maralixibati chloridum2
- maribavirum1
- marstacimabum1
- masitinibum1
- mavacamtenum1
- mavoglurantum1
- Medius AG4
- melphalanum1
- melphalanum flufenamidum1
- Mepha Pharma AG10
- mepolizumabum1
- mercaptamini bitartras2
- mercaptamini hydrochloridum2
- mercaptopurinum monohydricum1
- Merck (Schweiz) AG8
- Merkel细胞癌2
- mezigdomidum1
- midostaurinum2
- mifamurtidum1
- migalastati hydrochloridum1
- miglustatum3
- Minjuvi
- mirdametinibum2
- Mirum Pharmaceuticals AG2
- mirvetuximabum soravtansinum1
- MIT Gesundheit GmbH1
- mitotanum1
- mmpharm GmbH3
- mobocertinibum1
- mofetili mycophenolas1
- mogamulizumabum1
- momelotinibum3
- mosunetuzumabum2
- moxetumomabum pasudotoxum1
- Mozobil
- MSD Merck Sharp & Dohme AG7
- Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch2
- murine monoclonal CD26 antibody1
- Mylotarg
- Myozyme
N
- N-acetylgalaktosamini-6-sulfatasum1
- Naglazyme
- natrii phenylbutyras1
- navepegritidum1
- navitoclaxum1
- naxitamabum1
- nelarabinum1
- nelfinaviri mesilas1
- Neovii Pharmaceuticals AG2
- Netspot
- Nexavar
- NexoBrid
- Nexpovio
- Nexviadyme
- Ngenla
- Niemann-Pick病2
- nilotinibum2
- nimotuzumabum1
- Ninlaro
- nintedanibum3
- nipocalimabum1
- niraparibum1
- nirogacestatum1
- Nitisinon NOBEL
- Nitisinon NOBEL
- nitisinonum4
- NOBEL Pharma Schweiz AG6
- nonacogum alfa1
- Nordic Pharma GmbH2
- Norgine AG2
- Novartis Pharma Schweiz AG73
- Novo Nordisk Pharma AG8
- Nplate
- Nplate 125 mcg
- nusinersenum1
- NWBio Europe Sàrl, c/o Etude des avocats Marmier et as1
O
- obinutuzumabum3
- obrixtamigum2
- odevixibatum2
- odronextamabum2
- ofatumumabum1
- OFEV
- Ogsiveo
- Ojemda
- Ojemda
- olaparibum1
- olaratumabum1
- olezarsenum, olezarsenum natricum1
- olipudasum alfa1
- olomorasibum1
- OM Pharma Suisse SA2
- omaveloxolonum1
- ombrabulinum1
- Omjjara
- onasemnogenum abeparvovecum2
- Oncaspar
- Oncopeptides AB (publ)1
- Onivyde liposomal pégylé 4.3 mg/ml
- Onpattro
- Onureg
- Opfolda
- Opsumit
- Orchard Therapeutics (Netherlands) B.V.1
- Orkambi
- Orkambi
- Orladeyo
- OrPha Swiss GmbH6
- osilodrostatum1
- Otsuka Pharmaceutical (Switzerland) GmbH9
- oveporextonum1
- Oxervate
- Oxlumo
P
- paclitaxelum, albuminum1
- palopegteriparatidum1
- palovarotenum1
- panobinostatum2
- Parexel International (CH) AG1
- pasireotidum3
- patisiranum natricum1
- patupilonum3
- pazopanibum3
- PEG factor IX coagulationis humanus ADNr1
- pegaspargasum1
- pegcetacoplanum2
- pegunigalsidasum alfa1
- pegvisomantum1
- Pemazyre
- pemigatinibum2
- pevonedistatum2
- pexidartinibum1
- Peyona
- Pfizer AG26
- Pharma Mar, S.A.1
- pharma services Oehler GmbH1
- PharmaContext GmbH3
- PharmaMar AG6
- Pharvaris GmbH1
- Pheburane
- Phelinun
- Piasky
- Pierre Fabre Pharma SA2
- Pierre Fabre Pharma SA Usine Palézieux1
- PIK3CA相关过度生长谱系(PROS)1
- pimicotinibum1
- piperaquini tetraphosphas1
- pirfenidonum1
- pirtobrutinibum2
- pitolisanti hydrochloridum1
- Plenadren
- plerixaforum2
- plitidepsinum1
- PLX Healthcare Services (Schweiz) GmbH2
- polatuzumabum vedotinum1
- Polivy
- pomalidomidum5
- Pombiliti
- Pompe病(Ⅱ型糖原贮积病)4
- ponatinibum2
- Poteligeo
- pralatrexatum1
- pralsetinibum2
- Prevymis
- Prevymis
- Prevymis
- Prialt
- Procysbi
- Prolastin
- Prolastin-C Liquid
- propranololi hydrochloridum1
- proteina, factor IX coagulationis humanus, factor X coagulationis humanus1
- proteinum humanum C1
- Prothena Switzerland GmbH1
- PTC Therapeutics Switzerland GmbH2
Q
R
- Radicava
- Radicava
- raludotatugum deruxtecanum1
- ramucirumabum2
- ranibizumabum1
- ravulizumabum6
- Raxone
- Reblozyl
- recombinant fusion protein linking human coagulation factor VIIa with human albumin3
- recombinant human antibody directed against human misfolded superoxide dismutase 11
- recombinant human minibody against complement component C5 fused with RGD-motif1
- recombinant LJL143 protein from lutzomyia longipalpis saliva, recombinant KMP-11 promastigote protein from leishmania infantum, recombinant synthetic LeishF3+ fusion protein (NH/SMT from leishmania infantum)1
- RECORDATI AG11
- Recordati Rare Diseases1
- Refixia
- REGENERA SA1
- Regeneron Switzerland GmbH3
- regorafenibum1
- Remodulin
- repinatrabitum1
- Replagal
- resminostatum1
- retifanlimabum2
- Retsevmo
- Revatio
- Revatio
- Revestive
- REVLIMID
- Revolade
- rezafungini acetas1
- Rezzayo
- Rhythm Pharmaceuticals Switzerland GmbH4
- Riamet Baby
- ridaforolimusum2
- rilzabrutinibum1
- riociguatum4
- ripretinibum1
- risdiplamum2
- rituximabum3
- Rixubis
- Roche Pharma (Schweiz) AG33
- romidepsinum2
- romiplostimum2
- ropeginterferonum alfa-2b1
- rozanolixizumabum1
- Rozlytrek
- Rubraca
- rucaparibum1
- rufinamidum2
- rusfertidum1
- ruxolitinibum3
- Rydapt
- Rystiggo
S
- Sandoz Pharmaceuticals AG4
- Sanofi-Aventis (Suisse) SA13
- Santen SA1
- Santhera Pharmaceuticals (Schweiz) AG1
- Sapropterin NOBEL
- sapropterini dihydrochloridum2
- sapropterinum, sapropterini dihydrochloridum1
- Sarclisa
- satralizumabum2
- SBC-1031
- Scemblix
- Schircks Laboratories1
- Schweizerisches Tropen- und Public Health-Institut (Swiss TPH)1
- sebelipasum alfa1
- sebetralstatum1
- secukinumabum1
- seladelparum1
- selexipagum2
- selinexorum2
- selpercatinibum2
- selumetinibum1
- Sephience
- sepiapterinum1
- serplulimabum1
- Servier (Suisse) SA7
- setmelanotidum4
- SGX-0011
- sibeprenlimabum1
- Signifor
- Signifor LAR
- Sildenafil PAH-Mepha
- sildenafilum5
- siltuximabum1
- sirolimusum1
- sitaxentanum2
- Skyclarys
- Sogroya
- Soliris
- Somagenetix AG1
- somapacitanum1
- somatrogonum1
- Somavert
- sonidegibum1
- sonrotoclaxum1
- sorafenibum3
- sotaterceptum1
- sotorasibum2
- sparsentanum2
- spesolimabum2
- Spevigo
- Spevigo
- Spinraza
- Spirig HealthCare AG1
- Sprycel
- Stargardt病1
- Stemline Therapeutics Switzerland GmbH3
- stiripentolum2
- Strensiq
- streptozocinum1
- sulindacum, eflornithinum1
- sunitinibum2
- surovatamigum3
- susoctocogum alfa1
- Sutent
- sutimlimabum1
- Swedish Orphan Biovitrum AG10
- Sylvant
- Symdeko
T
- tabelecleucelum1
- Tabrecta
- Tadalafil PAH OrPha
- Tadalafil PAH-Mepha
- tadalafilum4
- tafamidisum3
- tafasitamabum2
- tagraxofuspum1
- Taiho Oncology Europe GmbH1
- Takeda Pharma AG31
- TAKHZYRO
- TAKHZYRO
- taletrectinibum1
- talquetamabum1
- Talvey
- Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug2
- Tapadar GmbH1
- Target BioScience AG1
- tarlatamabum1
- Tasigna
- Tavneos
- tebentafuspum1
- Tecartus
- teclistamabum1
- Tecvayli
- teduglutidum1
- telotristati etipras1
- temsirolimusum2
- Tepadina
- TEPADINA
- Tepkinly 4 mg/0
- Tepkinly 48 mg/0
- Tepmetko
- tepotinibum1
- Teva Pharma AG9
- tezacaftorum1
- tezacaftorum, ivacaftorum1
- TH-3022
- thiomolybdatum cholinum1
- thiotepum2
- Threshold Pharmaceuticals, c/o FGK Representative Service AG1
- Thromboreductin
- Tibsovo
- tinlarebantum1
- tinostamustinum1
- tioproninum1
- tisagenlecleucelum3
- TNF受体相关周期性综合征(TRAPS)1
- TOBI PODHALER
- tobramycinum1
- tocilizumabum1
- tofersenum1
- tolvaptanum1
- tominersenum1
- tovorafenibum2
- toxinum botulinicum B1
- trabectedinum2
- Tracleer
- Tracleer
- trastuzumabum emtansinum1
- Trecondi
- tremelimumabum1
- treosulfanum2
- Treprostinil OrPha
- treprostinilum3
- tretinoinum1
- triclabendazolum1
- trientini dihydrochloridum2
- trientini tetrahydrochloridum1
- Trikafta
- Trikafta
- Triogen
- Trisenox
- Triskel INTEGRATED SERVICES SA1
- tunlucabtagenum autoleucelum1
- turoctocogum alfa pegolum1
- turoctocogum alfa, histidinum, methioninum1
U
V
- vamikibartum1
- vamorolonum1
- Vancocin
- vancomycinum1
- vandetanibum1
- VANFLYTA
- vanzacaftorum, tezacaftorum, deutivacaftorum1
- VectivBio AG1
- velaglucerasum alfa1
- Velcade
- velmanasum alfa1
- Venclyxto
- venetoclaxum1
- Verkazia
- Vertex Pharmaceuticals (CH) GmbH11
- Vesanoid
- VEYVONDI
- Viatris Pharma GmbH3
- Vidaza
- Vifor (International) Inc.2
- Vifor Fresenius Medical Care Renal Pharma Ltd.3
- Vimizim
- vimseltinibum1
- Vitrakvi
- Vitrakvi
- voclosporinum1
- Voisin Consulting CH Sàrl2
- Volibris
- Von Hippel-Lindau病1
- Von Willebrand病1
- vonicogum alfa1
- Voranigo
- vorasidenibum1
- voretigenum neparvovecum1
- vosoritidum1
- Votrient
- Votubia
- Votubia
- voxelotorum1
- Voxzogo
- Voydeya
- VPRIV
- vutrisiranum natricum1
- Vyloy
- Vyndaqel 20 mg
- Vyndaqel 61 mg
- Vyvgart
- Vyvgart
- Vyxeos liposomal
W
X
Y
Z
无匹配结果
没有条目与此术语匹配。请检查拼写,或改为搜索活性物质,而不是品牌名称。
常见问题
药品如何在瑞士获得孤儿药资格?
向 Swissmedic 提出申请。申请所针对的疾病必须危及生命或造成慢性致残,且在瑞士每 10,000 人中受影响人数不超过 5 人;或者该药品已在药品监管水平相当的国家获得现有认可(TPA 第 4 条第 1 款 a decies 项,TPLO 第 4 条)。
该资格实际上带来什么?
简化许可程序(TPA 第 14 条第 1 款 f 项)、优先审评、免除新许可申请的统一费率费用,以及经申请获得 15 年的文件保护期(TPA 第 11b 条第 4 款)。该资格不提供欧盟式的市场独占权。
关于 A 至 Z 的数据有多新?
Swissmedic 依据 TPLO 第 7 条公布具有孤儿药资格的药品清单,并每月更新。此处处理的数据集日期显示在每个页面的页脚。
查看服务
将您的孤儿药引入瑞士
您可以咨询有关在瑞士获得孤儿药状态、批准和报销的问题。任何专业服务及其范围均由您与外部合作伙伴另行约定。
- 瑞士公开 Swissmedic 数据
- 四种语言版本